在体外血液净化方面的知识缺口:在败血症休克中成功应用它需要什么?
Sascha David1,2, Thomas Rimmelé3, Michael Joannidis4
1Department of Nephrology & Hypertension, Medical School Hannover, Hannover, Germany. sascha.david@usz.ch.
Intensive care medicine experimental
|November 20, 2025
概括
身体外血液净化 (EBP) 对败血症治疗有希望,但缺乏强有力的证据. 需要进一步的研究来了解其机制,并确定从这些疗法中受益的患者子组.
科学领域:
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 败血症是全球主要的死亡原因之一,其原因是宿主反应失调导致器官功能障碍.
- 身体外血液净化 (EBP) 疗法越来越多地用于消除炎症媒介,细胞和致病菌在败血症中.
- 尽管在临床上使用EBP,但对EBP在败血症休克中的疗效的强有力的证据是有限的,存在显著的知识差距.
研究的目的:
- 批判性地审查阻碍EBP在败血症中的有效和安全应用的机理学和临床知识差距.
- 检查免疫反应的复杂性,细胞因子的作用和EBP的潜在意外后果.
主要方法:
- 对EBP在败血症中的现有文献进行叙述性审查.
- 分析机械学方面,包括免疫调节和中介体去除.
- 评估临床试验数据,患者分层和治疗方案.
主要成果:
- 广谱吸附可能会导致意外的免疫调节效应.
- 选择性吸附在剂量,患者选择和测试限制方面面临挑战.
- 治疗性血交换引发了关于最佳治疗方案和潜在药物清除的问题.
- 临床试验显示了不确定的或相互矛盾的结果,其中一些表明潜在的危害.
结论:
- 更深入的机制理解和实时免疫监测对于EBP在败血症中的应用至关重要.
- 需要有针对性的临床试验设计,以确定受益于EBP的患者子组.
- 以免疫分析和生物标志物为指导的个性化治疗对于优化败血症EBP至关重要.
相关概念视频
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
180
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
180
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
165
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
165
Blood Pressure Imbalances and Circulatory Shock
1.4K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.4K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
379
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
379


